News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Naveen Pemmaraju: Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs
Naveen Pemmaraju/mdanderson.org
Mar 22, 2025, 12:47

Naveen Pemmaraju: Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs

Naveen Pemmaraju, Professor and Director of the BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared a paper he and his colleagues authored on X:

“Honored to be a part of this important international effort led by Dr. Nicola Polverelli.

Role of allo-HCT in nonclassical MPNs and MDS/MPNs: recommendations from the PH/G Committee and the CMWP of the EBMT.”

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared this post, adding:

“Honored to join colleagues on this important discussion regarding BMT/SCT and Myelofibrosis.”

Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH/G Committee and the CMWP of the EBMT.”

Authors: Nicola Polverelli et al.

Naveen Pemmaraju

Alessandro M. Vannucchi allo-HCT Andreas Reiter Annalisa Ruggeri Attilio Orazi Ayalew Tefferi cancer Carmelo Gurnari Christof Scheid Claire N. Harrison Daniel A. Arber Daniel Howard Wiseman Deepti H. Radia Domenico Russo Donal P McLornan Eric Padron Fabio Ciceri Fernando Barroso Duarte Francesca Palandri Francesco Onida Francesco Passamonti Gabriela S Hobbs Giorgia Battipaglia Ibrahim Yakoub-Agha Isabel Sánchez-Ortega Jason Gotlib Jean-Jacques Kiladjian Joanna Drozd-Sokolowska Joseph D. Khoury Juan Carlos Hernandez-Boluda Katja Sockel Kavita Raj Luca Arcaini Luca Malcovati Marie Robin Massimo Martino Michelle Kenyon Mrinal M Patnaik Naseema Gangat Naveen Pemmaraju Nicholas C.P. Cross Nico Gagelmann Nicola Polverelli Nicolaus Kröger OncoDaily Oncology Paola Guglielmelli Ruben Mesa Tania Jain Tomasz Czerw Vaneuza Araújo Moreira Funke Yves Chalandon
Special Coverage
Blog
Apr 18, 2025, 20:22
Applications are open for the ESMO Research Fellowship
Blog
Apr 18, 2025, 20:12
Caitríona Duggan: Delighted for the opportunity to share our work at MASCC
Blog
Apr 18, 2025, 20:03
Fumiko Ladd Chino: Honored to be invited to speak about financial toxicity
Blog
Apr 18, 2025, 20:02
Estelamari Rodriguez: ACS NLCRT Biomarker Workshop version of brainstorming with the stars
Blog
Apr 18, 2025, 19:54
Sami Mansfield: Fiber, the microbiome, and cancer care
Blog
Apr 18, 2025, 19:49
Eric K. Singhi Discusses Lung Cancer at ASCO 2025
Science
Apr 18, 2025, 19:44
Nirmala Bhoo Pathy: The need for race and ethnicity data in cancer control
Science
Apr 18, 2025, 19:28
Andreas Charalambous: Achieving digital transformation in cancer care across Europe
Blog
Apr 18, 2025, 19:26
SIOG - Older adults deserve better: Let’s close the gap in Cancer Care
Science
Apr 18, 2025, 19:10
Rafael Grochot: The safety and activity of FGFR inhibitors in early-phase clinical trials
Blog
Apr 18, 2025, 18:58
Mission Adaptation and Mission Cancer: Resilient Health Systems for Cancer - ECHoS
Blog
Apr 18, 2025, 18:55
Robert F. Kennedy Jr. visited U.S. FDA with Commissioner Martin Makary on Medical Innovation